The dual invoice system aims at improving transparency in drug prices and eliminating excessive profit margins associated with multi-tier distribution models. Photo: Xinhua

Good times ahead for Chinese pharmaceutical firms as policy environment turns favourable

Country’s renewed focus on health sector reforms could prove beneficial for sector, say analysts

Topic |   Broker's View

TOP PICKS

The dual invoice system aims at improving transparency in drug prices and eliminating excessive profit margins associated with multi-tier distribution models. Photo: Xinhua
READ FULL ARTICLE